Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?

Oncolytics Biotech Ownership Summary

Oncolytics Biotech is owned by 3.13% institutional investors, 2.78% insiders, and 94.10% retail investors. Renaissance is the largest institutional shareholder, holding 0.75% of ONCY shares. Invesco NASDAQ Future Gen 200 ETF is the top mutual fund, with 0.09% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oncolytics Biotech	3.13%	2.78%	94.10%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Renaissance	715.84K	0.75%	$607.60K
Sandbox financial partners	400.00K	0.42%	$339.52K
Seeds investor	258.31K	0.27%	$263.47K
Tocqueville asset management	149.00K	0.16%	$126.47K
Quadrature capital	106.08K	0.12%	$146.38K
Xtx topco	109.76K	0.11%	$93.16K
Lpl financial	78.90K	0.08%	$66.97K
Franklin resources	69.84K	0.07%	$71.31K
Geode capital management	66.94K	0.07%	$56.82K
Cibc world market	60.30K	0.06%	$51.26K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sandbox financial partners	400.00K	0.10%	$339.52K
Seeds investor	258.31K	0.04%	$263.47K
Security national bank of sioux city iowa /ia/	33.26K	0.02%	$28.23K
Vantage point financial	29.74K	0.01%	$25.25K
Scientech research	18.20K	0.01%	$25.49K
Headinvest	44.70K	0.01%	$37.94K
Two sigma securities	25.63K	0.00%	$21.75K
Tocqueville asset management	149.00K	0.00%	$126.47K
Quadrature capital	106.08K	0.00%	$146.38K
Xtx topco	109.76K	0.00%	$93.16K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	715.84K	0.00%	715.84K
Sandbox financial partners	400.00K	0.10%	400.00K
Quadrature capital	106.08K	0.00%	106.08K
Tocqueville asset management	149.00K	0.00%	77.00K
Cibc private wealth group	50.00K	0.00%	50.00K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	27.99K	-	-398.53K
Marshall wace, llp	-	-	-262.17K
International assets investment management	-	-	-208.15K
Goldman sachs group	-	-	-169.90K
Connective capital management	-	-	-150.34K

New Positions

Holder	Shares	% Assets	Change	Value
Renaissance	715.84K	0.00%	715.84K	$607.60K
Sandbox financial partners	400.00K	0.10%	400.00K	$339.52K
Quadrature capital	106.08K	0.00%	106.08K	$146.38K
Cibc private wealth group	50.00K	0.00%	50.00K	$43.70K
Fifth third bancorp	45.53K	0.00%	45.53K	$43.24K

Sold Out

Holder	Change
Russell investments group	-1.00
Pacifica partners	-100.00
Ifp advisors	-100.00
Evolution wealth management	-105.00
Dogwood wealth management	-146.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	56	-8.20%	2,996,321	7.11%	3	41.00%	30	36.36%	3	-40.00%
Dec 31, 2025	36	-35.71%	1,385,405	-50.88%	1	14.24%	9	-52.63%	2	-71.43%
Sep 30, 2025	30	-43.40%	910,881	-32.37%	1	39.52%	5	-76.19%	2	-60.00%
Jun 30, 2025	55	12.24%	1,492,518	10.47%	1	55.94%	23	9.52%	5	-28.57%
Mar 31, 2025	50	8.70%	1,365,517	3.85%	1	60.09%	22	-8.33%	7	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invesco NASDAQ Future Gen 200 ETF	107.52K	0.09%	-
Fidelity Nasdaq Composite Index	66.94K	0.06%	-
Vifag 2002 SICAV	30.00K	0.04%	-
Victory Extended Market Index	13.51K	0.01%	13.51K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 11, 2026	Parsons James T.	-	Buy	$10.30K
Mar 12, 2026	Kelly Jared	Chief Executive Officer	Buy	$4.85K
Feb 12, 2026	Kelly Jared	Chief Executive Officer	Buy	$24.84K
Feb 11, 2026	Kelly Jared	Chief Executive Officer	Buy	$4.68K
Feb 12, 2026	Look Kirk	Chief Financial Officer	Buy	$10.10K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	14	-

ONCY Ownership FAQ

Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 3.13%, followed by 2.78% insiders and 94.09% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 35.43%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Renaissance (715.84K shares, 0.75%), Sandbox financial partners (400K shares, 0.42%), and Seeds investor (258.31K shares, 0.27%). Together, they hold 1.43% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Sandbox financial partners is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 400K Oncolytics Biotech shares, valued at 339.52K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Invesco NASDAQ Future Gen 200 ETF is the top mutual fund holder of Oncolytics Biotech shares, with 0.09% of its total shares outstanding invested in 107.52K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools